MARC Record from harvard_bibliographic_metadata

LEADER: 02033cam a2200409 a 45 0
001 011143519-6
005 20111006233200.0
008 070921s2006 fr a b i101 0 eng
020 $a9789283212867
020 $a928321286X
040 $aCUD$cCUD$dCOU$dVAM
041 0 $aeng
042 $anlmcopyc
060 00 $aW1$bIA21I v.86 2006
060 10 $aQZ 202$bC652 2006
090 $aRA1231.M52$b.C6 2006
245 00 $aCobalt in hard metals and cobalt sulfate, gallium arsenide, indium phosphide, and vanadium pentoxide /$cIARC Working Group on the Evaluation of Carcinogenic Risks to Humans.
260 $aLyon, France :$bInternational Agency for Research on Cancer ;$aGeneva, Switzerland :$bDistributed by WHO Press,$c2006.
300 $axiv, 330 p. :$bill. ;$c24 cm.
440 0 $aIARC monographs on the evaluation of carcinogenic risks to humans,$x1017-1606 ;$vv. 86
500 $a"This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 7-14 October 2003."
500 $aAt head of title: World Health Organization, International Agency for Research on Cancer.
504 $aIncludes bibliographical references and index.
505 0 $aMetallic cobalt particles (with or without tungsten carbide) -- Introduction to the monographs on gallium arsenide and indium phosphide. Studies of cancer in humans -- Gallium arsenide -- Indium phosphide -- Vanadium pentoxide.
650 12 $aCarcinogens$xtoxicity
650 12 $aCarcinogenicity Tests
650 22 $aCobalt$xadverse effects
650 22 $aGallium$xadverse effects
650 22 $aIndium$xadverse effects
650 22 $aVanadium Compounds$xadverse effects
650 22 $aRisk Assessment
655 2 $aCongresses
711 2 $aIARC Working Group on the Evaluation of Carcinogenic Risks to Humans$d(2003 October 7-14 :$cLyon, France)
710 2 $aWorld Health Organization.
710 2 $aInternational Agency for Research on Cancer.
988 $a20070921
906 $0OCLC